- Home
- NSTS vs MGX Comparison
NSTS vs MGX Comparison
Compare NSTS & MGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSTS
- MGX
- Stock Information
- Founded
- NSTS 1921
- MGX 2018
- Country
- NSTS United States
- MGX United States
- Employees
- NSTS N/A
- MGX N/A
- Industry
- NSTS Savings Institutions
- MGX
- Sector
- NSTS Finance
- MGX
- Exchange
- NSTS Nasdaq
- MGX NYSE
- Market Cap
- NSTS 65.5M
- MGX 62.1M
- IPO Year
- NSTS N/A
- MGX 2024
- Fundamental
- Price
- NSTS $12.05
- MGX $2.43
- Analyst Decision
- NSTS
- MGX Strong Buy
- Analyst Count
- NSTS 0
- MGX 4
- Target Price
- NSTS N/A
- MGX $13.00
- AVG Volume (30 Days)
- NSTS 3.1K
- MGX 1.0M
- Earning Date
- NSTS 08-08-2025
- MGX 08-13-2025
- Dividend Yield
- NSTS N/A
- MGX N/A
- EPS Growth
- NSTS N/A
- MGX N/A
- EPS
- NSTS N/A
- MGX N/A
- Revenue
- NSTS $9,115,000.00
- MGX $45,263,000.00
- Revenue This Year
- NSTS N/A
- MGX N/A
- Revenue Next Year
- NSTS N/A
- MGX $3.97
- P/E Ratio
- NSTS N/A
- MGX N/A
- Revenue Growth
- NSTS 78.72
- MGX N/A
- 52 Week Low
- NSTS $9.37
- MGX $1.23
- 52 Week High
- NSTS $13.32
- MGX $4.92
- Technical
- Relative Strength Index (RSI)
- NSTS 46.01
- MGX 66.95
- Support Level
- NSTS $12.02
- MGX $1.98
- Resistance Level
- NSTS $12.39
- MGX $2.64
- Average True Range (ATR)
- NSTS 0.14
- MGX 0.23
- MACD
- NSTS -0.01
- MGX 0.04
- Stochastic Oscillator
- NSTS 51.92
- MGX 77.89
About NSTS NSTS Bancorp Inc.
NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in market area of Lake County, Illinois and adjacent communities.
About MGX METAGENOMI INC
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small edits such as programmable nucleases, base editors, small RNA-mediated integration systems (RIGS), as well as large gene integration systems including large template RIGS and CRISPR-associated transposases (CASTs). The company is focused on its vivo gene editing for its wholly-owned pipeline while pursuing technology out licensing for ex vivo cell therapy. Its pipeline includes product candidates aimed at addressing disorders like Hemophilia A (through MGX-001), Refractory Hypertension, Cardiovascular diseases, and Wilson's disease, among others.